V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003381 | 310001422 | 1.82 | 58 | Palliative (P) | 2015-09-22 | 2015-10-06 | Trial Unspecified | Y | null | 310017825 | TRIAL |
| 310003382 | 310001422 | null | 97.3 | Adjuvant (A) | 2013-04-04 | 2013-04-04 | Trial Unspecified | 01 | N | 310017825 | TRIAL |
| 310003383 | 310001422 | 1.66 | 97.6 | Curative (C) | 2016-04-01 | 2016-04-23 | Trial Unspecified | N | N | 310017825 | TRIAL |
| 310003384 | 310001422 | 1.79 | 70.1 | Palliative (P) | 2015-03-13 | 2015-03-16 | Trial Unspecified | N | N | 310017825 | TRIAL |
| 310003385 | 310001422 | null | 85 | Curative (C) | 2013-05-08 | 2013-05-11 | Retinoblastoma JOE | 02 | N | 310017825 | CEV |
| 310003386 | 310001423 | 1.52 | 61.6 | Curative (C) | 2013-07-02 | 2013-07-03 | Cisplatin | 02 | Y | 310017836 | CISPLATIN |
| 310003387 | 310001423 | 1.94 | 71.6 | Curative (C) | 2013-10-15 | 2013-10-16 | CHOP R - 21 days | N | N | 310017836 | CHOP R |
| 310003388 | 310001423 | 1.8 | null | Adjuvant (A) | 2016-12-24 | 2016-12-24 | Cisplatin | N | null | 310017836 | CISPLATIN |
| 310003389 | 310001424 | 1.88 | 65 | Curative (C) | 2017-02-25 | 2017-02-28 | Cisplatin | 02 | Y | 310017839 | CISPLATIN |
| 310003390 | 310001424 | 0 | 80.6 | Curative (C) | 2016-07-19 | 2016-08-08 | Retinoblastoma JOE | N | N | 310017839 | CEV |
| 310003391 | 310001424 | null | 96.8 | Curative (C) | 2014-01-26 | 2014-01-26 | Trial Unspecified | N | N | 310017839 | TRIAL |
| 310003392 | 310001425 | 1.75 | 62 | Curative (C) | 2013-12-21 | 2013-12-24 | CHOP R - 21 days | 02 | N | 310017845 | CHOP R |
| 310003393 | 310001425 | 1.6 | 70.2 | Palliative (P) | 2016-04-11 | 2016-04-16 | Doxorubicin 75mg/m2 | N | N | 310017845 | DOXORUBICIN |
| 310003394 | 310001425 | 1.6 | null | Adjuvant (A) | 2017-04-25 | 2017-04-26 | Cisplatin 7 day | 02 | Y | 310017845 | CISPLATIN |
| 310003395 | 310001425 | 0 | 97.2 | Curative (C) | 2014-11-17 | 2014-12-10 | Retinoblastoma JOE | N | N | 310017845 | CEV |
| 310003396 | 310001426 | 1.73 | 102.4 | Palliative (P) | 2016-11-20 | 2016-11-21 | PEMBROLIZUMAB | 02 | N | 310017850 | PEMBROLIZUMAB |
| 310003397 | 310001427 | null | null | Curative (C) | 2016-09-27 | 2016-10-23 | Retinoblastoma JOE | N | N | 310017853 | CEV |
| 310003398 | 310001427 | 1.79 | 83 | Palliative (P) | 2014-10-28 | 2014-12-06 | PEMBROLIZUMAB | N | N | 310017853 | PEMBROLIZUMAB |
| 310003399 | 310001428 | null | 60.7 | Palliative (P) | 2016-04-05 | 2016-05-04 | Ipilimumab | 2 | null | 310017856 | IPILIMUMAB |
| 310003400 | 310001429 | 1.77 | 85.4 | Palliative (P) | 2017-10-27 | 2017-11-02 | PEMBROLIZUMAB | 02 | N | 310017857 | PEMBROLIZUMAB |
| 310003401 | 310001430 | 1.82 | 100 | Palliative (P) | 2013-11-02 | 2013-11-02 | Ipilimumab | N | null | 310017860 | IPILIMUMAB |
| 310003402 | 310006604 | 1.71 | 76 | Palliative (P) | 2013-09-21 | 2013-09-21 | PEMBROLIZUMAB | N | N | 310017861 | PEMBROLIZUMAB |
| 310003403 | 310009048 | 1.89 | 79.6 | Palliative (P) | 2017-03-18 | 2017-03-19 | PEMBROLIZUMAB | 2 | N | 310017862 | PEMBROLIZUMAB |
| 310003404 | 310010330 | null | 111 | Palliative (P) | 2015-06-18 | 2015-06-21 | Carboplatin + Etoposide IV 3 day | 2 | N | 310017864 | CARBOPLATIN + ETOPOSIDE |
| 310003405 | 310011039 | 1.8 | 85.6 | Neo-adjuvant (N) | 2017-09-03 | 2017-09-09 | Cisplatin+Gemcitabine (Days 1&8&15) | 02 | N | 310017865 | CISPLATIN + GEMCITABINE |
| 310003406 | 310011436 | null | 71 | Adjuvant (A) | 2014-11-17 | 2014-11-19 | Cisplatin | Y | N | 310017868 | CISPLATIN |
| 310003407 | 310011660 | 1.73 | 75.5 | Curative (C) | 2015-06-01 | 2015-06-01 | Cisplatin 7 day | 02 | N | 310017871 | CISPLATIN |
| 310003408 | 310001431 | null | null | Curative (C) | 2016-01-24 | 2016-02-02 | Retinoblastoma JOE | N | N | 310017874 | CEV |
| 310003409 | 310001432 | 1.73 | null | Palliative (P) | 2017-08-14 | 2017-08-14 | Doxorubicin 75mg/m2 | 02 | null | 310017875 | DOXORUBICIN |
| 310003410 | 310001433 | 1.82 | 11.8 | Palliative (P) | 2016-05-09 | 2016-05-14 | Trial Unspecified | N | N | 310017876 | TRIAL |
| 310003411 | 310001433 | 1.61 | 79.5 | Palliative (P) | 2017-12-25 | 2017-12-25 | DOXORUBICIN | N | N | 310017876 | DOXORUBICIN |
| 310003412 | 310001433 | 1.7 | 75 | Palliative (P) | 2014-02-21 | 2014-02-22 | PEMBROLIZUMAB | N | N | 310017876 | PEMBROLIZUMAB |
| 310003413 | 310001434 | 1.61 | 81 | Palliative (P) | 2017-12-13 | 2017-12-24 | Doxorubicin 75mg/m2 | null | N | 310017881 | DOXORUBICIN |
| 310003414 | 310006606 | 1.59 | null | Palliative (P) | 2016-04-27 | 2016-05-13 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 310017882 | CISPLATIN + GEMCITABINE |
| 310003415 | 310001435 | 1.66 | 7 | Palliative (P) | 2013-06-29 | 2013-06-30 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017889 | CISPLATIN + GEMCITABINE |
| 310003416 | 310001435 | 1.78 | 127.9 | Palliative (P) | 2017-03-24 | 2017-04-21 | CISPLATIN + GEMCITABINE | N | N | 310017889 | CISPLATIN + GEMCITABINE |
| 310003417 | 310001436 | null | 60 | Palliative (P) | 2018-01-30 | 2018-01-31 | Ipilimumab | N | N | 310017892 | IPILIMUMAB |
| 310003418 | 310001436 | null | 12.1 | Curative (C) | 2015-10-06 | 2016-10-04 | Ipilimumab | N | N | 310017892 | IPILIMUMAB |
| 310003419 | 310001436 | null | 93.9 | Disease modification (D) | 2014-09-18 | 2014-10-01 | CARBOPLATIN + ETOPOSIDE | null | N | 310017892 | CARBOPLATIN + ETOPOSIDE |
| 310003420 | 310001436 | 1.64 | 69.8 | Palliative (P) | 2017-08-01 | 2017-08-01 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017892 | CISPLATIN + GEMCITABINE |
| 310003421 | 310001436 | 1.63 | null | Palliative (P) | 2015-04-09 | 2015-04-14 | Doxorubicin 75mg/m2 | 02 | N | 310017892 | DOXORUBICIN |
| 310003422 | 310001436 | 1.6 | 95.7 | Palliative (P) | 2016-03-26 | 2016-03-31 | Ipilimumab | N | N | 310017892 | IPILIMUMAB |
| 310003423 | 310001436 | null | 49.4 | null | 2015-02-04 | 2015-03-08 | CHOP R - 21 days | N | Y | 310017892 | CHOP R |
| 310003424 | 310011792 | 1.6 | 59.4 | Curative (C) | 2013-05-23 | 2013-06-27 | Cisplatin | N | Y | 310017910 | CISPLATIN |
| 310003425 | 310011870 | 1.79 | 103 | Palliative (P) | 2016-01-17 | 2016-01-20 | DOXORUBICIN | 2 | N | 310017911 | DOXORUBICIN |
| 310003426 | 310001437 | 1.83 | 80 | Curative (C) | 2014-03-08 | 2014-03-08 | Cisplatin | N | Y | 310017913 | CISPLATIN |
| 310003427 | 310001437 | 1.69 | 68.4 | null | 2018-08-06 | 2018-08-12 | Trial Unspecified | Y | N | 310017913 | TRIAL |
| 310003428 | 310001438 | 1.93 | 14.6 | null | 2013-11-07 | 2013-11-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017917 | CISPLATIN + GEMCITABINE |
| 310003429 | 310006610 | 1.55 | null | Palliative (P) | 2014-03-19 | 2014-03-19 | Carboplatin + Etoposide iv&po | 02 | null | 310017918 | CARBOPLATIN + ETOPOSIDE |
| 310003430 | 310006610 | 1.8 | 91.7 | Curative (C) | 2013-06-23 | 2013-06-23 | Cisplatin 7 day | N | N | 310017918 | CISPLATIN |